PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Another study has demonstrated that the PPARGC1A rs8192678 risk A allele is associated with nonalcoholic fatty liver disease (NAFLD) and more severe forms of liver steatosis and activity grades in NAFLD patients, independent of PNPLA3 rs738409.